New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage ...
Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard ...
The world’s first early-detection blood test for pancreatic cancer is set to be launched in Australia, and is predicted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results